Cleared Traditional

K811703 - CARDIFF ALDASORBER SYSTEM

K811703 · William Harvey Life Products Corp. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1981
Decision
-
Days
-
Risk

K811703 is an FDA 510(k) clearance for the CARDIFF ALDASORBER SYSTEM.

Submitted by William Harvey Life Products Corp. (Mchenry, US). The FDA issued a Cleared decision on June 16, 1981.

This device falls under the Cardiovascular FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all William Harvey Life Products Corp. devices

FDA 510(k) Submission Details - K811703

510(k) Number K811703 FDA.gov
FDA Decision Cleared Substantially Equivalent - Product Development Protocol (SESP)
Date Received June 16, 1981
Decision Date June 16, 1981
Days to Decision -
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Pathway characteristics
Predicate-based equivalence.

Device Classification - Class ,

Product Code -
Device Class -